To investigate the proliferation integrity of CD34+ cells that expressed NKG2D-Ls, in subsequent experiments, we determined the clonogenic potential of purified NKG2D-L+ and NKG2D-L– CD34+ cells from 2 patients with FA. The gene discussed is CD34; the disease is Friedreich ataxia.